Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

This study has been terminated.
(Low events rate. Scarce economical resources)
Sponsor:
Collaborator:
A.R. CARD Onlus Foundation
Information provided by (Responsible Party):
David Antoniucci, Careggi Hospital
ClinicalTrials.gov Identifier:
NCT01790854
First received: February 12, 2013
Last updated: July 28, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)